Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 May 29;4(1):100340. doi: 10.1016/j.xops.2023.100340

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by the American Academy of Ophthalmology.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Clinical outcome in patients with atopic dermatitis (AD) treated with dupilumab. A, Eczema Area and Severity Index (EASI) score, (C) Investigator Global Assessment (IGA) score, (B) percentage of improvement in EASI, and (D) IGA during different visits of patients with AD and dupilumab–associated ocular surface disease (DAOSD). Data are presented in box and whisker plots showing minimum, maximum, and median values; a diminutive (+) indicates mean values, () gray dotted lines indicate the mean value at baseline in AD, and () orange dotted lines indicate the mean value at baseline in DAOSD. N = 6–14. One-way analysis of variance was used for statistical testing. NA = not applicable.

Inline graphic — Clinical outcome in patients with atopic dermatitis (AD) treated with dupilumab. A, Eczema Area and Severity Index (EASI) score, (C) Investigator Global Assessment (IGA) score, (B) percentage of improvement in EASI, and (D) IGA during different visits of patients with AD and dupilumab–associated ocular surface disease (DAOSD). Data are presented in box and whisker plots showing minimum, maximum, and median values; a diminutive (+) indicates mean values, () gray dotted lines indicate the mean value at baseline in AD, and () orange dotted lines indicate the mean value at baseline in DAOSD. N = 6–14. One-way analysis of variance was used for statistical testing. NA = not applicable.